Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, hispanic, and other minority families in the United States

Journal of Clinical Oncology

Volumn 27, Issue 8, 2009, Pages 1184-1190

  Olopade, Olufunmilayo I ^a   Huo, Dezheng ^a   Seme, Ruby T ^a   Daly, Mary ^a   Buys, Saundra S ^a   Cummings, Shelly ^a   Ogutha, Jacqueline ^a   Hope, Kisha ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ADULT; AFRICAN AMERICAN; AGED; AREA UNDER THE CURVE; ARTICLE; ASIAN AMERICAN; BRCAPRO MODEL; BREAST CANCER; CANCER REGISTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EUROPE; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HISPANIC; HUMAN; JEW; MAJOR CLINICAL STUDY; MINORITY GROUP; ONCOGENE; OVARIECTOMY; OVARY CANCER; POPULATION RESEARCH; POPULATION RISK; PREDICTION; PRIORITY JOURNAL; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; MINORITY GROUPS; MUTATION; OVARIECTOMY;

EID: 62449256610     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.17.5869     Document Type: Article

References (37)

1. Chen S, Parmigiani G: Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25: 1329-1333, 2007
2. Robson M, Offit K: Management of an inherited predisposition to breast cancer. N Engl J Med 357:154-162, 2007
3. Parmigiani G, Berry D, Aguilar O: Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62: 145-158, 1998
4. Antoniou AC, Pharoah PD, McMullan G, et al: A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86:76-83, 2002
5. Couch FJ, DeShano ML, Blackwood MA, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415, 1997
6. Evans DG, Eccles DM, Rahman N, et al: A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41:474-480, 2004
7. Frank TS, Deffenbaugh AM, Reid JE, et al: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals. J Clin Oncol 20:1480-1490, 2002
8. Apicella C, Andrews L, Hodgson SV, et al: Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Res 5:R206-R216, 2003
9. Marroni F, Aretini P, D'Andrea E, et al: Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet 41:278-285, 2004
10. Barcenas CH, Hosain GM, Arun B, et al: Assessing BRCA carrier probabilities in extended families. J Clin Oncol 24:354-360, 2006
11. Berry DA, Iversen ES Jr. Gudbjartsson DF, et al: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701-2712, 2002
12. Euhus DM, Smith KC, Robinson L, et al: Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94:844-851, 2002
13. James PA, Doherty R, Harris M, et al: Optimal selection of individuals for BRCA mutation testing: A comparison of available methods. J Clin Oncol 24: 707-715, 2006
14. Kang HH, Williams R, Leary J, et al: Evaluation of models to predict BRCA germline mutations. Br J Cancer 95:914-920, 2006
15. Weitzel JN, Lagos VI, Cullinane CA, et al: Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297: 2587-2595, 2007
16. Parmigiani G, Chen S, Iversen ES Jr. et al: Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147:441-450, 2007
17. 17.Nanda R, Schumm LP, Cummings S, et al: Genetic testing in an ethnically diverse cohort of high-risk women: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925-1933, 2005
18. Vogel KJ, Atchley DP, Erlichman J, et al: BRCA1 and BRCA2 genetic testing in Hispanic patients: Mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol 25:4635-4641, 2007
19. Armstrong K, Micco E, Carney A, et al: Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293:1729-1736, 2005
20. Hall M, Olopade Ol: Confronting genetic testing disparities: Knowledge is power. JAMA 293: 1783-1785, 2005
21. US Census Bureau: Census 2000 data for the United States, http://www.census.gov/census2000/ states/us.html
22. Katki HA: Incorporating medical interventions into carrier probability estimation for genetic counseling. BMC Med Genet 8:13, 2007
23. Chen S, Wang W, Broman KW, et al: Bayes- Mendel: An R environment for Mendelian risk prediction. Stat Appl Genet Mol Biol 3:Article21, 2004
24. John EM, Hopper JL, Beck JC, et al: The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6:R375-R389, 2004
25. R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2006
26. DeGroot M, Fienberg S: The comparison and evaluation of forecasters. Statistician 32:12-22, 1983
27. Spiegelhalter DJ: Probabilistic prediction in patient management and clinical trials. Stat Med 5:421-433, 1986
28. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonpara- metric approach. Biometrics 44:837-845, 1988
29. Pepe MS: The Statistical Evaluation of Medical Tests for Classification and Prediction. New York City, NY, Oxford University Press, 2003
30. Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689, 1998
31. Brier G: Verification of forecasts expresssed in terms of probability. Monthly Weather Rev 78:1-3, 1950
32. Antoniou AC, Durocher F, Smith P, et al: BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8:R3, 2006
33. Oros KK, Ghadirian P, Maugard CM, et al: Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent. Clin Genet 70:320-329, 2006
34. Apicella C, Dowty JG, Dite GS, et al: Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women. Clin Genet 72:87-97, 2007
35. Rao NY, Hu Z, Li WF, et al: Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat 113:467-477, 2009
36. Huo D, Olopade Ol: Genetic testing in diverse populations: Are researchers doing enough to get out the correct message? JAMA 298:2910-2911, 2007
37. John EM, Miron A, Gong G, et al: Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869-2876, 2007